Comparison

WRVYEKC(dnp)ALK (tetraTFA) European Partner

Item no. HY-P4227A-1mg
Manufacturer MedChem Express
Amount 1 mg
Quantity options 1 mg 5 mg
Specific against other
Purity 98.91
Citations [1]Nguyen TT, et al. Structural basis for antigenic peptide precursor processing by the endoplasmic reticulum aminopeptidase ERAP1. Nat Struct Mol Biol. 2011 May;18(5):604-13.
Smiles OC(C=C1)=CC=C1C[C@@H](C(N[C@@H](CCC(O)=O)C(N[C@@H](CCCCN)C(N[C@H](C(N[C@@H](C)C(N[C@@H](CC(C)C)C(N[C@H](C(O)=O)CCCCN)=O)=O)=O)CSC2=C(C=C(C=C2)[N+]([O-])=O)[N+]([O-])=O)=O)=O)=O)NC([C@H](C(C)C)NC([C@H](CCCNC(N)=N)NC([C@@H](N)CC3=CNC4=CC=CC=C34)=O)=O)=O.OC(C(F)(F)F)=O.OC(C(F)(F)F)=O.OC(C(F)(F)F)=O.OC(C(F)(F)F)=O
Available
Product Description
WRVYEKC(dnp)ALK tetraTFA contains tryptophan that can be liberated from the dinitrophenol (DNP) quencher by aminopeptidase activity. WRVYEKC(dnp)ALK tetraTFA can be used as a hydrolysis reaction decapeptide substrate[1].
StorageTemperature
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light, under nitrogen)
Shipping
Blue Ice
Manufacturers Applications
Metabolism-protein/nucleotide metabolism
MolecularWeight
1917.74
Clinical Information
No Development Reported
Manufacturers Research Area
Metabolic Disease
Solubility
10 mM in DMSO
Target
Others
Manufacturers Target
Others
Manufacturers Pathway
Others
Manufacturers Product type
Peptides

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close